Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127554431 | 12755443 | 1 | I | 20160909 | 20160916 | 20160916 | EXP | BR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-60103BI | BOEHRINGER INGELHEIM | DIAZ C,SEGURA E,LUZ P,CLARK J,RIBEIRO S,DE BONI R,ET AL. TRADITIONAL AND HIV-SPECIFIC RISK FACTORS FOR CARDIOVASCULAR MORBIDITY AND MORTALITY AMONG HIV-INFECTED ADULTS IN BRAZIL: A RETROSPECTIVE COHORT STUDY. BMC INFECTIOUS DISEASES 2016;16:376. | 36.00 | YR | M | Y | 0.00000 | 20160916 | OT | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127554431 | 12755443 | 1 | PS | VIRAMUNE | NEVIRAPINE | 1 | Unknown | U | 201152 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127554431 | 12755443 | 1 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127554431 | 12755443 | DE |
| 127554431 | 12755443 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127554431 | 12755443 | Cardiac failure congestive | |
| 127554431 | 12755443 | Myocardial infarction | |
| 127554431 | 12755443 | Myocardial ischaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |